287 related articles for article (PubMed ID: 28560782)
1. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.
Teerlink JR; Metra M; Filippatos GS; Davison BA; Bartunek J; Terzic A; Gersh BJ; Povsic TJ; Henry TD; Alexandre B; Homsy C; Edwards C; Seron A; Wijns W; Cotter G;
Eur J Heart Fail; 2017 Nov; 19(11):1520-1529. PubMed ID: 28560782
[TBL] [Abstract][Full Text] [Related]
2. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
[TBL] [Abstract][Full Text] [Related]
3. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
4. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
Bartunek J; Davison B; Sherman W; Povsic T; Henry TD; Gersh B; Metra M; Filippatos G; Hajjar R; Behfar A; Homsy C; Cotter G; Wijns W; Tendera M; Terzic A
Eur J Heart Fail; 2016 Feb; 18(2):160-8. PubMed ID: 26662998
[TBL] [Abstract][Full Text] [Related]
5. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
Bartunek J; Terzic A; Davison BA; Filippatos GS; Radovanovic S; Beleslin B; Merkely B; Musialek P; Wojakowski W; Andreka P; Horvath IG; Katz A; Dolatabadi D; El Nakadi B; Arandjelovic A; Edes I; Seferovic PM; Obradovic S; Vanderheyden M; Jagic N; Petrov I; Atar S; Halabi M; Gelev VL; Shochat MK; Kasprzak JD; Sanz-Ruiz R; Heyndrickx GR; Nyolczas N; Legrand V; Guédès A; Heyse A; Moccetti T; Fernandez-Aviles F; Jimenez-Quevedo P; Bayes-Genis A; Hernandez-Garcia JM; Ribichini F; Gruchala M; Waldman SA; Teerlink JR; Gersh BJ; Povsic TJ; Henry TD; Metra M; Hajjar RJ; Tendera M; Behfar A; Alexandre B; Seron A; Stough WG; Sherman W; Cotter G; Wijns W;
Eur Heart J; 2017 Mar; 38(9):648-660. PubMed ID: 28025189
[TBL] [Abstract][Full Text] [Related]
6. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
[TBL] [Abstract][Full Text] [Related]
7. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
[TBL] [Abstract][Full Text] [Related]
8. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model.
Emmert MY; Wolint P; Jakab A; Sheehy SP; Pasqualini FS; Nguyen TDL; Hilbe M; Seifert B; Weber B; Brokopp CE; Macejovska D; Caliskan E; von Eckardstein A; Schwartlander R; Vogel V; Falk V; Parker KK; Gyöngyösi M; Hoerstrup SP
Biomaterials; 2017 Apr; 122():48-62. PubMed ID: 28107664
[TBL] [Abstract][Full Text] [Related]
10. Association of QRS duration with left ventricular volume and ejection fraction after anterior myocardial infarction assessed by gated single photon emission computed tomography.
Kurisu S; Sumimoto Y; Ikenaga H; Ishibashi K; Fukuda Y; Kihara Y
Acta Cardiol; 2018 Aug; 73(4):371-376. PubMed ID: 29073826
[TBL] [Abstract][Full Text] [Related]
11. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
Zhang J; Lin L; Zong W
Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure.
Shen T; Xia L; Dong W; Wang J; Su F; Niu S; Wang Q; Fang Y
Curr Stem Cell Res Ther; 2021; 16(3):354-365. PubMed ID: 32867655
[TBL] [Abstract][Full Text] [Related]
14. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
15. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
Stockburger M; Gómez-Doblas JJ; Lamas G; Alzueta J; Fernández-Lozano I; Cobo E; Wiegand U; Concha JF; Navarro X; Navarro-López F; de Teresa E
Eur J Heart Fail; 2011 Jun; 13(6):633-41. PubMed ID: 21613427
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
[TBL] [Abstract][Full Text] [Related]
17. The extent of early left ventricular reverse remodelling is related to midterm outcomes after restrictive mitral annuloplasty in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation.
Takeda K; Sakaguchi T; Miyagawa S; Shudo Y; Kainuma S; Masai T; Taniguchi K; Sawa Y
Eur J Cardiothorac Surg; 2012 Mar; 41(3):506-11. PubMed ID: 22011774
[TBL] [Abstract][Full Text] [Related]
18. The optimal definition and prediction nomogram for left ventricular remodelling after acute myocardial infarction.
Zhang S; Zhu Z; Luo M; Chen L; He C; You Z; He H; Lin M; Zhang L; Lin K; Guo Y
ESC Heart Fail; 2023 Oct; 10(5):2955-2965. PubMed ID: 37489064
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
20. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
